Japan has been considerably contributing to the growth of the market. The major factors driving the market are government policies, high geriatric population, and adoption of robotic surgeries. Japan is a technologically sound nation, which is equipped with innovative methods for various heart surgeries. Government of Japan initiated various awareness programs through Japanese Society for cardiovascular surgery. The awareness level for heart diseases is increasing in Japan and the adoption of surgeries is also increasing at a modest rate. Various universities, R&D institutes, Hospitals and clinics are exploring cardiology surgeries through R&D to come up with innovative approaches and devices for cardiology surgeries. The companies active in the defibrillators market are Boston Scientific, USCI Holdings, HeartSine Technologies, Boston Scientific, Medtronic and so on.Critical surgeries for heart are expected to be performed through robots in Japan during the forecast period.
Japan has the least number of CVD cases as there are very few fatal cases for heart attack, cancer, or diabetes. Japan has comparatively lower mortality rate as compared to other Asian countries such as India, China, and South Korea. The average life expectancy in Japan is around 70-75 years. According to WHO, the fatality rate in Japan due to CHD is about 31 among 100,000 cases. However, the mortality rate may increase due life style-oriented diseases and high geriatric population base. The rate of CHD in Japan is quite low as compared to western developed economies as it is nearer to 150 per 100,000 people in the UK and the US, whereas it is near to 50 per 100,000 in Japan. The diabetes rate in Japanese is quite less than the Americans, however they smoke more cigarettes and have high cholesterol as compared to Americans. Other reasons for low rate of CVD in Japan include high fish consumption and low sugar consumption. They both act as a major factor responsible for heart attack or cardiac arrest, contributing to the market growth.
Research Methodology
The market study of the Japan Defibrillators market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Japan Defibrillators Market Research and Analysis by Type
2. Japan Defibrillators Market Research and Analysis by End-users
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Japan Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Japan Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Biotronik SE & Co. KG
6.3. Defibtech, LLC
6.4. Fukuda Denshi Co. Ltd.
6.5. General Electric Co.
6.6. HeartSine Technologies
6.7. Koninklijke Philips N.V.
6.8. LivaNova PLC
6.9. Medtronic PLC
6.10. Nihon Kohden Corp.
6.11. Stryker Corp.
6.12. USCI Holdings
1. JAPAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. JAPAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
1. JAPAN DEFIBRILLATORS MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. JAPAN DEFIBRILLATORS MARKET SHARE BY END-USERS, 2018 VS 2025 (%)